Sam Neill Declares Cancer‑Free After CAR‑T Trial
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Sam Neill says a scan shows no cancer after CAR T‑cell therapy trial, making him cancer‑free.
- CAR T‑cell therapy costs over A$600,000 privately and is currently limited to public hospitals for certain blood cancers in Australia.
- 7News broadcast Neill’s announcement while he urged Australian state and federal governments to expand CAR T‑cell access nationwide.
- The Guardian previously reported Neill’s chemo regimen and his "not afraid to die" stance, highlighting his long fight with angioimmunoblastic T‑cell lymphoma.
- 2025 US study documented an 18‑year remission in a neuroblastoma patient treated with CAR T‑cell therapy, underscoring its potential beyond blood cancers.
Why it matters: Australian blood‑cancer patients gain a proven, life‑saving option while the public health system faces pressure to fund a $600k+ therapy, reshaping reimbursement and accelerating trial enrollment.
Ask SkimNews
